Literature DB >> 10588303

Gradient plate method to induce Streptococcus pyogenes resistance.

H Carsenti-Etesse1, P M Roger, B Dunais, S Durgeat, G Mancini, M Bensoussan, P Dellamonica.   

Abstract

In recent years, increasing numbers of Streptococcus pyogenes (GAS) strains displaying resistance to macrolides have been reported in Finland, Japan, Asia and Spain. Antibiotic use has been shown to be a risk factor for infection with and carriage of drug-resistant streptococci. The aim of this study was to compare in-vitro development of resistance of streptococci to beta-lactams (penicillin, amoxycillin, cefotiam and cefuroxime) and erythromycin by serial passages in subinhibitory concentrations of antibiotics (subMICs) by gradient plate method. Three clinical strains of GAS were tested. Two were susceptible to erythromycin (MIC = 0.015 mg/L and 0.013 mg/L) and one resistant. Serial passages were performed daily by gradient plate method until a four-fold increase of the MIC was achieved. GAS variants obtained after serial passages in beta-lactams had MICs increased at least four-fold. They remained susceptible to these antibiotics. With erythromycin, final MICs reached intermediate and resistant level. Results obtained in this study with erythromycin are in good correlation with clinical studies showing that prior exposure to macrolides may help to facilitate the emergence of drug-resistant strains of streptococci.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588303     DOI: 10.1093/jac/44.4.439

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  The Bifidobacterium longum NCIMB 702259T ctr gene codes for a novel cholate transporter.

Authors:  Claire E Price; Sharon J Reid; Arnold J M Driessen; Valerie R Abratt
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

2.  Impact of dose de-escalation and escalation on daptomycin's pharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitro model.

Authors:  Celine Vidaillac; Molly E Steed; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2011-02-14       Impact factor: 5.191

3.  Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents.

Authors:  M Braoudaki; A C Hilton
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.